Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 8041 AL 8055

Recent synthetic advances in the preparation of 1,3-thiazole compounds and their therapeutic applications in degenerative diseases

Chaudhari P, Danta CC, Nefzi A.

Org Biomol Chem. 2025 Oct 22;23(41):9257-9284. doi: 10.1039/d5ob01199j.

Effects of monoclonal antibody therapies on depression in Parkinson's disease and Alzheimer's disease: Systematic review and meta-analysis

Gitlin-Leigh G, Wilson J, Howard R, Howard R, Costello H.

J Alzheimers Dis. 2025 Nov;108(2):500-508. doi: 10.1177/13872877251378156. Epub 2025 Sep 19.

Nanomedicine-Driven Modulation of the Gut-Brain Axis: Innovative Approaches to Managing Chronic Inflammation in Alzheimer's and Parkinson's Disease

Krsek A, Schleicher LMS, Jagodic A, Baticic L.

Int J Mol Sci. 2025 Sep 19;26(18):9178. doi: 10.3390/ijms26189178.

Effects of Ghrelin Hormone on Alzheimer's and Parkinson's Disease: A Systematic Review of the Existing Literature

Abdulazeez Y, Utami RN, Al-Jamal KT, Mok ZH.

ACS Chem Neurosci. 2025 Nov 5;16(21):4159-4171. doi: 10.1021/acschemneuro.5c00683. Epub 2025 Oct 23.

Repetitive transcranial magnetic stimulation for cognitive and emotional symptoms in neurodegenerative diseases: a systematic review and dose-response meta-analysis

Zhang Y, Liu S, Xu K, Shen Y, Liu Z, Wang Y, Bai Y, Wang S.

Neurol Sci. 2025 Dec;46(12):6243-6259. doi: 10.1007/s10072-025-08531-x. Epub 2025 Nov 5.

Drug enteric metabolism in gut microbiota-brain crosstalk

Maramai S, Taddei M, Castagnetti A, Viciani E, Koufi FD, Neri I, Boschetti E, Evangelisti C, Ratti S, Baldelli L, Calandra-Buonaura G, Cani I, Cortelli P, Sambati L, Scorziello A, Taglialatela M, Pardini M, Corsaro A, Florio T, Giannini G.

Life Sci. 2025 Dec 15;383:124075. doi: 10.1016/j.lfs.2025.124075. Epub 2025 Nov 7.

EEG-based stratification in Alzheimer's disease: Cognitive progression, pathological marker associations, and therapeutic interventions

Pei Z, Zhu L, Ren H, Liu Y, Shi X, Lin Y, Wang J, Li P, Wang P, Ji Y, Zhou Y, Tang X, Jiang X, Tong X, Guo Y.

Clin Neurophysiol. 2026 Jan;182:2111440. doi: 10.1016/j.clinph.2025.2111440. Epub 2025 Nov 15.

Advances in neurological therapies: A review of clinical trials in Alzheimer's, Parkinson's, and multiple sclerosis

de Souza PC, Bezerra TPW, de Melo Rêgo MJB, da Rosa MM.

Am J Med. 2026 Mar;139(3):264-275. doi: 10.1016/j.amjmed.2025.11.025. Epub 2025 Nov 27.

GLP-1 receptor agonists in Alzheimer's and Parkinson's disease: endocrine pathways, clinical evidence, and future directions

Gandhi A, Parhizgar A.

Front Endocrinol (Lausanne). 2025 Nov 20;16:1708565. doi: 10.3389/fendo.2025.1708565. eCollection 2025.

Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024

Isaković J, Athanassiadis A, Khubeis M.

J Mol Med (Berl). 2025 Dec 13;104(1):2. doi: 10.1007/s00109-025-02613-1.

Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases

Simão S, Santos DF, Teixeira M, Agostinho RR, Rodrigues J, Vitorino M, Araújo IM.

Redox Rep. 2026 Dec;31(1):2592413. doi: 10.1080/13510002.2025.2592413. Epub 2025 Dec 15.

Speech and language outcome measures in clinical trials of Alzheimer's and Parkinson's diseases

Berthier ML, Sosa-Welford A, Orozco-Arroyave JR, López-Barroso D, Torres-Prioris MJ, Dávila G, García AM.

Expert Rev Neurother. 2026 Jan;26(1):15-34. doi: 10.1080/14737175.2025.2600616. Epub 2025 Dec 16.

BACE1: Biological Functions and Involvement in the Pathophysiology of Alzheimer's Disease and Other Neurological Disorders

Bartolić M, Bosak A.

Biofactors. 2025 Nov-Dec;51(6):e70071. doi: 10.1002/biof.70071.

[Neurogenesis in neurodegeneration: multifactorial regulation, mechanisms of impairment, and therapeutic strategies]

Yusupov FA, Abdykadyrov MS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(12):14-21. doi: 10.17116/jnevro202512512114.

Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases

Chinnathambi S, Rangappa N.

Adv Protein Chem Struct Biol. 2026;151:157-195. doi: 10.1016/bs.apcsb.2025.10.014. Epub 2025 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias